Gadi Veinrib

NetVision Ltd. operates in the communication sector of international telephony services in Israel. The company offers communication solutions and services among which Internet and international calls for organizations, businesses and private users. It also offers information security services, hosting services, anti-virus services, website filtering and telephony products and services using cutting-edge technological solutions. NetVision was founded by Alon Zvi and is headquartered in Haifa, Israel.

Nana 10 Ltd. operates television channel and news website. The company was founded in January 2002 and is headquartered in Givatayim, Israel.

RDSeed Ltd (RDSeed) is a venture capital subsidiary of RDC Rafael Development Corp Ltd founded in 2011 by Dror Liwer. The firm is headquartered in Tel Aviv, Israel.

Cloudyn Software Ltd. provides cloud monitoring and cost optimization for cloud infrastructure (IaaS) deployments. It offers AWS, azure, google, OpenStack and cost allocation 360° solutions. Its SaaS solution delivers unprecedented insights into usage, performance and cost, coupled with custom prescriptive actions for enhancing performance and reducing cloud spend. The company was founded by Sharon Wagner, Boris Goldberg and Vittaly Tavor in 2011 and is headquartered in Rosh HaAyin, Israel.

Meteo-Logic Ltd. provides custom-made weather forecasting. Its focus is to bring algo-trading and weather prediction capabilities to the energy commodity market, in order to leverage the enormous financial opportunities and data-driven future predictions ranging from minutes to days ahead, opening a new niche in commodity trading with reduced competition by avoiding crowded high-frequency algo-trading arenas. The company was founded by Igal Zivoni in 2010 and is headquartered in Ramot hashavim, Isreal.

Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel.